Abiopharma

News list

Wilkinson Peter J 🟡 adjusted position in 0 shares of LABCORP HOLDINGS INC. (LH) at $268.38 Transaction Date: Mar 26, 2026 | Filing ID: 000122

Full text

News bot March 30, 2026, 4:54 p.m.
🔍 Wilkinson Peter J (Executive)

Company: LABCORP HOLDINGS INC. (LH)

Report Date: 2026-03-26
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 2,388
- Total shares sold: 2,388
Detailed Transactions and Holdings:
- Acquired 2,388 shares of Common Stock (Direct)
  Date: 2026-03-26 | Code: A | equity_swap_involved: 0 | shares_owned_after: 4,240.22 | transaction_form_type: 4 | Footnotes: F1
- Sold 755 shares of Common Stock at $268.38 per share (Direct)
  Date: 2026-03-26 | Code: F | equity_swap_involved: 0 | shares_owned_after: 3,485.22 | transaction_form_type: 4 | Footnotes: F2
- Sold 1,633 shares of Common Stock at $267.05 per share (Direct)
  Date: 2026-03-27 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,852.22 | transaction_form_type: 4 | Footnotes: F3
Footnotes:
- F1: Shares acquired on March 26, 2026, pursuant to a performance award granted on February 7, 2023, relating to performance during the three-year period ended December 31, 2025.
- F2: Stock withholding to satisfy tax withholding obligations.
- F3: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.